Mouse models of human INAD by Pla2g6 deficiency

Histology and Histopathology

Volumn 28, Issue 8, 2013, Pages 965-969

  Wada, Haruka ^a   Kojo, Satoshi ^a   Seino, Ken Ichiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

INAD; IPla2 ; Neuroaxonal dystrophy; Phospholipase; Pla2g6

Indexed keywords

PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 GROUP VI; PLA2G6 PROTEIN, HUMAN; PLA2G6 PROTEIN, MOUSE;

ALLELE; ANIMAL; DEGENERATIVE DISEASE; DISEASE MODEL; GENETICS; HEMATOPOIESIS; HUMAN; KNOCKOUT MOUSE; METABOLISM; MOUSE; MUTATION; NEUROAXONAL DYSTROPHY; POINT MUTATION; REVIEW; SITE DIRECTED MUTAGENESIS;

ALLELES; ANIMALS; DISEASE MODELS, ANIMAL; GROUP VI PHOSPHOLIPASES A2; HEMATOPOIESIS; HUMANS; MICE; MICE, KNOCKOUT; MUTAGENESIS, SITE-DIRECTED; MUTATION; NEUROAXONAL DYSTROPHIES; NEURODEGENERATIVE DISEASES; PHOSPHOLIPASES A2; POINT MUTATION;

EID: 84880416459     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Balsinde J. and Balboa M.A. (2005). Cellular regulation and proposed biological functions of group via calcium-independent phospholipase a2 in activated cells. Cell Signal. 17, 1052-1062.
2. Balsinde J., Balboa M.A. and Dennis E.A. (1997). Antisense inhibition of group vi ca2+-independent phospholipase a2 blocks phospholipid fatty acid remodeling in murine p388d1 macrophages. J. Biol. Chem. 968 272, 29317-29321.
3. Barlow J.K., Sims K.B. and Kolodny E.H. (1989). Early cerebellar degeneration in twins with infantile neuroaxonal dystrophy. Ann. Neurol. 25, 413-415.
4. Beck G., Sugiura Y., Shinzawa K., Kato S., Setou M., Tsujimoto Y., Sakoda S. and Sumi-Akamaru H. (2011). Neuroaxonal dystrophy in calcium-independent phospholipase a2beta deficiency results from insufficient remodeling and degeneration of mitochondrial and presynaptic membranes. J. Neurosci. 31, 11411-11420.
5. Biancheri R., Rossi A., Alpigiani G., Filocamo M., Gandolfo C., Lorini R. and Minetti C. (2007). Cerebellar atrophy without cerebellar cortex hyperintensity in infantile neuroaxonal dystrophy (inad) due to pla2g6 mutation. Eur. J. Paediatr. Neurol. 11, 175-177.
6. Burke J.E. and Dennis E.A. (2009). Phospholipase a2 biochemistry. Cardiovasc Drugs Ther. 23, 49-59.
7. Carrilho I., Santos M., Guimaraes A., Teixeira J., Chorao R., Martins M., Dias C., Gregory A., Westaway S., Nguyen T., Hayflick S. and Barbot C. (2008). Infantile neuroaxonal dystrophy: What's most important for the diagnosis? Eur. J. Paediatr. Neurol. 12, 491-500.
8. Farina L., Nardocci N., Bruzzone M.G., D'Incerti L., Zorzi G., Verga L., Morbin M. and Savoiardo M. (1999). Infantile neuroaxonal dystrophy: Neuroradiological studies in 11 patients. Neuroradiology 41, 376-380.
9. Green J.T., Orr S.K. and Bazinet R.P. (2008). The emerging role of group vi calcium-independent phospholipase a2 in releasing docosahexaenoic acid from brain phospholipids. J. Lipid Res. 49, 939-944.
10. Gregory A., Westaway S.K., Holm I.E., Kotzbauer P.T., Hogarth P., Sonek S., Coryell J.C., Nguyen T.M., Nardocci N., Zorzi G., Rodriguez D., Desguerre I., Bertini E., Simonati A., Levinson B., Dias C., Barbot C., Carrilho I., Santos M., Malik I., Gitschier J. and Hayflick S.J. (2008). Neurodegeneration associated with genetic defects in phospholipase a(2). Neurology 71, 1402-1409.
11. Hooks S.B. and Cummings B.S. (2008). Role of ca2+-independent phospholipase a2 in cell growth and signaling. Biochem. Pharmacol. 76, 1059-1067.
12. Khateeb S., Flusser H., Ofir R., Shelef I., Narkis G., Vardi G., Shorer Z., Levy R., Galil A., Elbedour K. and Birk O.S. (2006). Pla2g6 mutation underlies infantile neuroaxonal dystrophy. Am. J. Hum. Genet. 79, 942-948.
13. Malik I., Turk J., Mancuso D.J., Montier L., Wohltmann M., Wozniak D.F., Schmidt R.E., Gross R.W. and Kotzbauer P.T. (2008). Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by pla2g6 mutations. Am. J. Pathol. 172, 406-416.
14. Morgan N.V., Westaway S.K., Morton J.E., Gregory A., Gissen P., Sonek S., Cangul H., Coryell J., Canham N., Nardocci N., Zorzi G., Pasha S., Rodriguez D., Desguerre I., Mubaidin A., Bertini E., Trembath R.C., Simonati A., Schanen C., Johnson C.A., Levinson B., Woods C.G., Wilmot B., Kramer P., Gitschier J., Maher E.R. and Hayflick S.J. (2006). Pla2g6, encoding a phospholipase a2, is mutated in neurodegenerative disorders with high brain iron. Nat. Genet. 38, 752-754.
15. Murakami M., Taketomi Y., Miki Y., Sato H., Hirabayashi T. and Yamamoto K. (2011). Recent progress in phospholipase a(2) research: From cells to animals to humans. Prog. Lipid Res. 50, 152-192.
16. Nardocci N., Zorzi G., Farina L., Binelli S., Scaioli W., Ciano C., Verga L., Angelini L., Savoiardo M. and Bugiani O. (1999). Infantile neuroaxonal dystrophy: Clinical spectrum and diagnostic criteria. Neurology 52, 1472-1478.
17. Shinzawa K. and Tsujimoto Y. (2003). Pla2 activity is required for nuclear shrinkage in caspase-independent cell death. J. Cell Biol. 163, 1219-1230.
18. Shinzawa K., Sumi H., Ikawa M., Matsuoka Y., Okabe M., Sakoda S. and Tsujimoto Y. (2008). Neuroaxonal dystrophy caused by group via phospholipase a2 deficiency in mice: A model of human neurodegenerative disease. J. Neurosci. 28, 2212-2220.
19. Strokin M., Sergeeva M. and Reiser G. (2003). Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase a2 and is differently regulated by cyclic amp and ca2+. Br. J. Pharmacol. 139, 1014-1022.
20. Tanabe Y., Iai M., Ishii M., Tamai K., Maemoto T., Ooe K. and Takashima S. (1993). The use of magnetic resonance imaging in diagnosing infantile neuroaxonal dystrophy. Neurology 43, 110-113.
21. Tonelli A., Romaniello R., Grasso R., Cavallini A., Righini A., Bresolin N., Borgatti R. and Bassi M.T. (2010). Novel splice-site mutations and a large intragenic deletion in pla2g6 associated with a severe and rapidly progressive form of infantile neuroaxonal dystrophy. Clin. Genet. 78, 432-440.
22. van Diggelen O.P., Schindler D., Kleijer W.J., Huijmans J.M., Galjaard H., Linden H.U., Peter-Katalinic J., Egge H., Dabrowski U. and Cantz M. (1987). Lysosomal alpha-n-acetylgalactosaminidase deficiency: A new inherited metabolic disease. Lancet 2, 804.
23. Wada H., Yasuda T., Miura I., Watabe K., Sawa C., Kamijuku H., Kojo S., Taniguchi M., Nishino I., Wakana S., Yoshida H. and Seino K. (2009). Establishment of an improved mouse model for infantile neuroaxonal dystrophy that shows early disease onset and bears a point mutation in pla2g6. Am. J. Pathol. 175, 2257-2263.
24. Wu Y., Jiang Y., Gao Z., Wang J., Yuan Y., Xiong H., Chang X., Bao X., Zhang Y., Xiao J. and Wu X. (2009). Clinical study and pla2g6 mutation screening analysis in chinese patients with infantile neuroaxonal dystrophy. Eur. J. Neurol. 16, 240-245.
25. Yagishita S. and Kimura S. (1974). Infantile neuroaxonal dystrophy. Histological and electron microscopical study of two cases. Acta Neuropathol. 29, 115-126.
26. Zhao Z., Wang J., Zhao C., Bi W., Yue Z. and Ma Z.A. (2011). Genetic ablation of pla2g6 in mice leads to cerebellar atrophy characterized by purkinje cell loss and glial cell activation. PLoS One 6, e26991.